All In Biotech

Drug Trial Radar · NCT01061437

S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)

A Phase III Randomized Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori

Last checked: Nov 20, 2026Latest source record: Sep 26, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,859 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,859

Actual

Start

Jun 2009

Primary completion

Jul 2011

Study completion Jul 2011

Sponsor

Lead sponsor
SWOG Cancer Research NetworkResearch network
Sponsor type
Research network
Collaborators
Bill and Melinda Gates Foundation
First posted
Feb 3, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 21 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the effectiveness of three different antibiotic regimens against Helicobacter pylori (H. pylori).

Conditions

  • Helicobacter Pylori Infection

Interventions

  • PACx14Drug

    Standard 14 day, 3 drug regimen: lansoprazole, amoxicillin, clarithromycin (PACx14)

  • PACMx5Drug

    Concomitant therapy - 5 day, 4 drug regimen: lansoprazole, amoxicillin, clarithromycin, metronidazole (PACMx5)

  • PAx5/PCMx5Drug

    Sequential Therapy - 10 day, 4-drug regimen: lansoprazole, amoxicillin for 5 days, followed by lansoprazole, clarithromycin and metronidazole for 5 days (PAx5/PCMx5)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To compare 2 experimental antibiotic regimens with a standard 14 day regimen with regard to H. pylori eradication rates at 6 weeks post-randomization.Time frame: week 6 post-randomization

Locations

7 sites in 6 countries. Site status is shown where the registry gives one.

  • Pontificia Universidad Catolica de Chile

    Santiago, Chile

  • Universidad del Valle

    Cali, Valle del Cauca Department, Colombia

  • Fundacion Inciensa

    San José, Costa Rica

  • Hospital Occidente

    Copán, Honduras

  • National Institute for Public Health

    Cuernavaca, Morelos, Mexico

  • Instituto Technologico de Sonora

    Obregón, Sonora, Mexico

  • Centro de Investigacion en Demografia y Salud de la Iglesia Merced

    León, Nicaragua

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.